Cargando…

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

Detalles Bibliográficos
Autores principales:	Cooper, WN, Dickinson, RE, Dallol, A, Hesson, LB, Bieche, I, Clark, GJ, Maher, ER, Zabarovsky, ER, Latif, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300712/ http://dx.doi.org/10.1186/bcr1893

Ejemplares similares

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers
por: Dickinson, R E, et al.
Publicado: (2004)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Epigenetically inactivated RASSF1A as a tumor biomarker
por: Raos, Dora, et al.
Publicado: (2021)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

Identification of 5 novel genes methylated in breast and other epithelial cancers
por: Hill, Victoria K, et al.
Publicado: (2010)

RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
por: Richter, Antje M., et al.
Publicado: (2020)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

The cellular functions of RASSF1A and its inactivation in prostate cancer
por: Amin, Karishma S., et al.
Publicado: (2012)

Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma
por: Calvisi, Diego F., et al.
Publicado: (2012)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
por: Perez-Janices, Noemi, et al.
Publicado: (2015)

Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation
por: Montenegro, María F., et al.
Publicado: (2012)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers
por: Dunwell, Thomas, et al.
Publicado: (2010)

The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
por: Pangeni, Rajendra P., et al.
Publicado: (2015)

The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
por: Jiménez, Adriana P., et al.
Publicado: (2017)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
por: García-Gutiérrez, Lucía, et al.
Publicado: (2020)

Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis
por: Li, Mingyi, et al.
Publicado: (2019)

ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
por: Ma, Sean S. Q., et al.
Publicado: (2016)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer
por: Kristiansen, Søren, et al.
Publicado: (2016)

RASSF1A and the Taxol Response in Ovarian Cancer
por: Kassler, Susannah, et al.
Publicado: (2012)

The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
por: Richter, A M, et al.
Publicado: (2012)

Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma
por: Korah, Reju, et al.
Publicado: (2013)

RASSF1A Signaling in the Heart: Novel Functions beyond Tumor Suppression
por: Del Re, Dominic P., et al.
Publicado: (2012)

High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer
por: Kashuba, Vladimir I., et al.
Publicado: (2009)

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
por: Astuti, D, et al.
Publicado: (2004)

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours
por: Curmi, P A, et al.
Publicado: (2000)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer
por: Vu, Trang Lan, et al.
Publicado: (2018)

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
por: Gil, Eun Young, et al.
Publicado: (2017)

Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients
por: Jezkova, Eva, et al.
Publicado: (2017)

An Optimized CoBRA Method for the Microfluidic Electrophoresis Detection of Breast Cancer Associated RASSF1 Methylation
por: Aibel, Claire, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p8hl8lp822vaok9ophieq8pimh